Clinical trial
Study to Examine the Effect on Glucose Control and Safety/Tolerability of…
NCT00111540 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00111540 |
|---|---|
| Title | Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes |
| Official title | An Open Label Study to Examine the Long Term Effect on Glucose Control (HbA1c) and Safety and Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes Mellitus |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | exenatide |
| Enrollment | 456 |
| Start date | Nov 1, 2002 |
| Primary completion | Sep 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | May 24, 2005 |
| Last update posted | Feb 23, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: